MOLECULAR AND CLINICAL CONDITIONS ASSOCIATED WITH VENOUS THROMBOEMBOLISM IN ONCOLOGICAL PATIENTS
P. Di Micco1, 2, *, M. Amitrano3, A. Niglio4, A. Fontanella1
1Division of Internal Medicine, Buonconsiglio Fatebenefratelli Hospital of Naples, Naples, Italy 2Department of Biochemistry and Medical Biotechnology and CEINGE SCARL, Federico II University of Naples, Naples, Italy 3Division of Angiology, A.O.R.N. G. Moscati, Avellino, Italy 4IV Division of Internal Medicine, Second University of Naples, Naples, Italy
Abstract. The association between cancer and thrombophilia has been known since
1865 since Trousseau described it. However in the last three decades an increased interest
has been raised on this issue related to several molecular and condition that are involved
in the daily management of oncological patients. This brief review has been focused on
molecular conditions underlying cancer acquired thrombophilia then to further clinical
aspects inducing thrombophilia in oncological patients such as surgery, chemotherapy,
concomitant medical illness and inherited thrombophilia.